A Challenge Trial for COVID-19 Would Not Be the First of Its Kind
A Challenge Trial for COVID-19 Would Not Be the First of Its Kind
Although scientists debate the ethics of deliberately infecting volunteers with SARS-CoV-2, plenty of consenting participants have been exposed to all sorts of pathogens in prior trials.
A Challenge Trial for COVID-19 Would Not Be the First of Its Kind
A Challenge Trial for COVID-19 Would Not Be the First of Its Kind

Although scientists debate the ethics of deliberately infecting volunteers with SARS-CoV-2, plenty of consenting participants have been exposed to all sorts of pathogens in prior trials.

Although scientists debate the ethics of deliberately infecting volunteers with SARS-CoV-2, plenty of consenting participants have been exposed to all sorts of pathogens in prior trials.

hookworm
Researchers Analyze Genomes of 81 Parasitic Worm Species
Researchers Analyze Genomes of 81 Parasitic Worm Species
Ashley P. Taylor | Nov 5, 2018
The new data could help identify treatments for diseases ranging from river blindness to schistosomiasis.
Image of the Day: Hungry Hookworms
Image of the Day: Hungry Hookworms
The Scientist Staff, The Scientist Staff | Mar 26, 2018
Researchers discover anti-malarials called quinolones can halt the development of the parasites, offering a potential therapeutic avenue.
Genome Digest
Genome Digest
Jenny Rood | Mar 4, 2015
What researchers are learning as they sequence, map, and decode species’ genomes